New restrictions for controversial diabetes drug, Avandia
After nearly a decade of controversy and debates, a particular diabetes medication is being heavily restricted because of the associated risks with heart attacks in patients who have taken it.
Restrictions on Avandia will officially go into effect in November, and are aimed at curbing the usage of the drug.
Starting in November, the drug will only be available by mail order at select pharmacies. The drug's manufacturer will no longer be allowed to promote the drug, and doctors will be unable to prescribe it to new patients without explaining, in detail, the dangers that it could potentially pose.
For more information, .